Natixis Advisors LLC increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 180,720 shares of the semiconductor company's stock after acquiring an additional 9,012 shares during the quarter. Natixis Advisors LLC owned approximately 0.12% of Synopsys worth $87,714,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of the company. Caprock Group LLC boosted its stake in Synopsys by 0.5% during the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company's stock valued at $1,803,000 after purchasing an additional 20 shares during the period. Compagnie Lombard Odier SCmA boosted its stake in Synopsys by 1.1% during the 4th quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company's stock valued at $898,000 after purchasing an additional 20 shares during the period. Edge Capital Group LLC boosted its stake in Synopsys by 1.2% during the 4th quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company's stock valued at $791,000 after purchasing an additional 20 shares during the period. Barden Capital Management Inc. boosted its stake in Synopsys by 1.1% during the 4th quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company's stock valued at $889,000 after purchasing an additional 20 shares during the period. Finally, Resurgent Financial Advisors LLC boosted its stake in Synopsys by 2.8% during the 3rd quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company's stock valued at $410,000 after purchasing an additional 22 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.
Wall Street Analysts Forecast Growth
SNPS has been the subject of a number of research analyst reports. Morgan Stanley reduced their price target on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research note on Monday, February 24th. Robert W. Baird reduced their price target on shares of Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a research note on Thursday, December 5th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $660.00 price target on shares of Synopsys in a research note on Tuesday, February 25th. Redburn Atlantic initiated coverage on shares of Synopsys in a research note on Monday, January 13th. They issued a "buy" rating and a $600.00 price target for the company. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $650.00 price target on shares of Synopsys in a research note on Thursday, February 27th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, Synopsys presently has an average rating of "Moderate Buy" and an average price target of $638.58.
Read Our Latest Analysis on SNPS
Insider Buying and Selling
In related news, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now directly owns 116,671 shares in the company, valued at $51,850,925.82. This represents a 11.86 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CRO Richard S. Mahoney sold 20,838 shares of the company's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company's stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 47,909 shares of company stock valued at $22,794,835. Company insiders own 0.62% of the company's stock.
Synopsys Trading Up 4.1 %
NASDAQ SNPS opened at $446.23 on Friday. The company has a fifty day simple moving average of $495.89 and a 200 day simple moving average of $508.31. The company has a market cap of $69.00 billion, a P/E ratio of 30.73, a P/E/G ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 1 year low of $425.73 and a 1 year high of $624.80.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.